Home › Dikkedarmkanker › Illinois › Chicago
Dikkedarmkanker klinische studies in Chicago, IL
14 studies voor Dikkedarmkanker zoeken deelnemers op locaties in en rond Chicago (binnen ongeveer 30 mijl). Open een studie om te zien wie er kan deelnemen en hoe je contact opneemt met het studieteam.
Officiële studietekst (Engels)
Rekruteren voor een studie? Laat deze bovenaan deze pagina verschijnen — $99 voor 30 dagen →
Family Communications After Genetic Testing
RekruterenGezonde vrijwilligers welkom
- Advocate Illinois Masonic Medical Center, Chicago
PRE-ISPY Phase I/II Oncology Platform Program
RekruterenFase 1/2
- The University of Chicago Medicine Comprehensive Cancer Center, Chicago
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
RekruterenFase 3
- Illinois Cancer Specialists, Chicago
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
RekruterenFase 3
- University of Illinois Cancer Center, Chicago
Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
Rekruteren
- John H Stroger Jr Hospital of Cook County, Chicago
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
RekruterenFase 2/3
- Mount Sinai Hospital Medical Center, Chicago
- Northwestern University, Chicago
- John H Stroger Jr Hospital of Cook County, Chicago
- en nog 5
BMS-986504 in Combination With Pemetrexed for the Treatment of Metastatic Solid Tumors With MTAP Deletion
RekruterenFase 1/2
- Northwestern University, Chicago
Shield Post-Approval Study Protocol
RekruterenObservatieonderzoekGezonde vrijwilligers welkom
- GI Solutions of Illinois, Chicago
- GI Solutions of Illinois, Chicago
Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma
RekruterenFase 1
- Xencor Investigative Site, Chicago
- Xencor Investigative Site, Chicago
Neoadjuvant Botensilimab and Balstilimab for the Treatment of Advanced Resectable Colorectal Cancer NEST3
RekruterenFase 2
- City of Hope at Illinois Chicago Downtown, Chicago
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
RekruterenFase 1/2
- University of Chicago, Chicago
Exogenous and Endogenous Risk Factors for Early-onset Colorectal Cancer
RekruterenObservatieonderzoekGezonde vrijwilligers welkom
- Section of Gastroenterology, Hepatology, and Nutrition, Department of Medicine University of Chicago Medicine, Chicago
Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer
RekruterenFase 3
- GSK Investigational Site, Chicago
- GSK Investigational Site, Chicago
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruterenObservatieonderzoek
- Massive Bio SYNERGY-AI site, Chicago
Dikkedarmkanker studies in andere steden
- Boston, MA22 studies
- New York City, NY22 studies
- Houston, TX20 studies
- Los Angeles, CA16 studies
- Nashville, TN16 studies
- St. Louis, MO15 studies
- Arlington, VA15 studies
- San Antonio, TX14 studies
- Baldwin Park, CA14 studies
- Baltimore, MD13 studies
- Tampa, FL13 studies
- Washington, DC12 studies
Andere studies in Chicago
- Niet-kleincellige longkanker61 studies
- Borstkanker59 studies
- Kanker (alle vormen)51 studies
- Metastatische kanker45 studies
- Prostaatkanker45 studies
- Longkanker41 studies
- Obesitas41 studies
- Eierstokkanker36 studies
- Colorectale kanker34 studies
- Beroerte34 studies
- Hartfalen31 studies
- Overgewicht29 studies
Van ClinicalTrials.gov, gegevens opgehaald op 6 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.